A [review in the BMJ](https://bit.ly/34YyXfz) of SARS-CoV-2 diagnostic and outcome prognosis preprints and peer-reviewed studies in a collaboration between european researchers and the Cochrane Prognosis Group finds them all subject to mostly sampling bias and clinically unusable.